Reduction of digoxin toxicity associated with measurement of serum levels. A report from the Boston Collaborative Drug Surveillance Program.
D001900:Boston; D004077:Digoxin / Q000008:administration & dosage / Q000009:adverse effects* / Q000097:blood; D004334:Drug Administration Schedule; D005069:Evaluation Studies as Topic; D006760:Hospitalization; D006761:Hospitals; D006801:Humans; D008991:Monitoring, Physiologic / Q000379:methods; D009994:Osmolar Concentration; D011863:Radioimmunoassay; D012307:Risk Factors
D004077:Digoxin